BioSpace News Archive

McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.

Imunon, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 8,500 shares of common stock and restricted stock grants totaling 2,250 shares of common stock as a material inducement to the employment to two individuals hired by Imunon during the third quarter of 2022.

The Muscular Dystrophy Association celebrates the US Food and Drug Administration approval of sodium phenylbutyrate/taurursodiol for the treatment of amyotrophic lateral sclerosis, on September 29.

Aditxt, Inc announces it has received confirmation from The Nasdaq Stock Market LLC Hearing Panel that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550, meets the stockholders’ equity requirement in Nasdaq Listing Rule 5550 and meets all other applicable criteria for continued listing.

Biofrontera Inc. announced that Erica Monaco, Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference being held at the Yale Club in New York City on October 6, 2022.

City of Hope announced a $15 million gift from City of Hope patient and cancer survivor Ted Schwartz that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the chimeric antigen receptor T cell therapy that saved his life.

The latest market analysis report published by Reports and Data, titled ‘Global Behcets Syndrome Treatment Market – Forecast to 2030,’ thoroughly examines the Behcets Syndrome Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Corneal Ulcer Treatment Market – Forecast to 2030,’ thoroughly examines the Corneal Ulcer Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Glomerulonephritis Market – Forecast to 2030,’ thoroughly examines the Glomerulonephritis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Pseudomonas Aeruginosa Infection Treatment Market – Forecast to 2030’ thoroughly examines the Pseudomonas Aeruginosa Infection Treatment Market industry to provide essential data & information for the targeted readers